银诺医药-B及银诺技术合共认购1.25亿元宁波银行结构性存款产品

Core Viewpoint - Silver诺医药-B (02591) announced that on December 1, 2025, the company and its wholly-owned subsidiary, Silver诺技术, will subscribe to a structured deposit product from Ningbo Bank for a total consideration of RMB 125 million, which is equivalent to its total principal amount [1] Group 1 - The total investment amount for the structured deposit product is RMB 125 million [1] - The investment will be made by both Silver诺医药-B and its subsidiary Silver诺技术 [1] - The subscription is set to take place on December 1, 2025 [1]